Skip to main navigation Skip to search Skip to main content

Rituximab: standaardtherapie bij non-Hodgkin lymfoom

Research output: Contribution to journalArticleProfessional

Original languageDutch
Pages (from-to)20
JournalTijdschrift Kanker
Volume31
Publication statusPublished - 2007

Cite this